0.00
Acelyrin Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
See More
Previous Close:
$2.27
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$227.15M
Revenue:
-
Net Income/Loss:
$-299.80M
P/E Ratio:
0.00
EPS:
-2.84
Net Cash Flow:
$-217.49M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
Acelyrin Inc Stock (SLRN) Company Profile
Name
Acelyrin Inc
Sector
Industry
Phone
805-456-4393
Address
4149 LIBERTY CANYON RD., AGOURA HILLS
Compare SLRN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SLRN
Acelyrin Inc
|
0.00 | 227.15M | 0 | -299.80M | -217.49M | -2.84 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 60.58B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 54.99B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
674.90 | 42.25B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.93B | 3.81B | -644.79M | -669.77M | -6.24 |
Acelyrin Inc Stock (SLRN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Aug-14-24 | Downgrade | H.C. Wainwright | Buy → Neutral |
Jul-08-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Dec-13-23 | Initiated | Wells Fargo | Equal Weight |
Dec-08-23 | Initiated | Citigroup | Neutral |
Sep-13-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Sep-05-23 | Initiated | H.C. Wainwright | Buy |
May-30-23 | Initiated | Jefferies | Buy |
May-30-23 | Initiated | Morgan Stanley | Overweight |
May-30-23 | Initiated | Piper Sandler | Overweight |
May-30-23 | Initiated | TD Cowen | Outperform |
View All
Acelyrin Inc Stock (SLRN) Latest News
What are analysts’ price targets for Acelyrin Inc. in the next 12 monthsInvest like a pro with expert recommendations - Jammu Links News
How does Acelyrin Inc. compare to its industry peersInvest confidently with professional guidance - Jammu Links News
Is it the right time to buy Acelyrin Inc. stockTurn market volatility into profit opportunities - Jammu Links News
What markets is Acelyrin Inc. expanding into Is SEVN stock a good long term investment option - Jammu Links News
What institutional investors are buying Acelyrin Inc. stockSky-high return potential - Jammu Links News
What is the dividend policy of Acelyrin Inc. stockFree Expert Stock Watchlist - Jammu Links News
What catalysts could drive Acelyrin Inc. stock higher in 2025Master stock selection with insider knowledge - Jammu Links News
Is Acelyrin Inc. stock overvalued or undervaluedBuild wealth faster with disciplined trading - Jammu Links News
Should I hold or sell Acelyrin Inc. stock in 2025Exceptional stock performance - Jammu Links News
How volatile is Acelyrin Inc. stock compared to the marketCapitalize on emerging market opportunities - Jammu Links News
Why is Acelyrin Inc. stock attracting strong analyst attentionBuild a diversified portfolio for risk management - Jammu Links News
How does Acelyrin Inc. generate profit in a changing economyPre Market Trend Scanner From AI Tools - Jammu Links News
What are the technical indicators suggesting about Acelyrin Inc.Post Market Outlook For Every Investor - jammulinksnews.com
What is the risk reward ratio of investing in Acelyrin Inc. stockWealth Building Growth Plan For Consistent Profits - Jammu Links News
Alumis (ALMS) Merges with ACELYRIN - Insider Monkey
Sentiment Tools Show Shift in Trader Mood on Acelyrin Inc.AI Screening for Swing Trade Picks Finds Momentum - metal.it
Fibonacci Support Holding Strong in Acelyrin Inc.Secure Capital Picks With Upside Potential Tracked - metal.it
What makes Acelyrin Inc. stock price move sharplyReliable Alerts for Daily Stock Movers Released - metal.it
Published on: 2025-07-28 22:52:55 - metal.it
How many analysts rate Acelyrin Inc. as a “Buy”Entry Signal Trend Scanner For Fast Growth - jammulinksnews.com
Acelyrin Inc. Company’s Quarterly Earnings Growth: What the Numbers SayReliable High Profit Alerts - metal.it
Is Acelyrin Inc. Stock a Smart Buy in 2025 Investment Analysis InsideBig Profit Small Risk Alerts - beatles.ru
What drives Acelyrin Inc. stock priceFree Predictions - PrintWeekIndia
Is Acelyrin Inc. a good long term investmentExceptional profit velocity - PrintWeekIndia
Does Acelyrin Inc. stock pay reliable dividendsConsistent wealth multiplication - jammulinksnews.com
Acelyrin Inc. Stock Analysis and ForecastExplosive wealth accumulation - jammulinksnews.com
What analysts say about Acelyrin Inc. stockTriple-digit wealth increases - Autocar Professional
Acelyrin Inc Stock (SLRN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):